baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BNP Paribas Discount Zert 6MK 24..../ DE000PC56UP7 /

5/16/2024 5:20:42 PM	Chg.-0.290	Bid5:47:45 PM	Ask5:47:45 PM	Underlying	Strike price	Expiration date	Option type
108.130EUR	-0.27%	107.990 Bid Size: 3,000	108.040 Ask Size: 3,000	MERCK CO. D...	- -	6/24/2026	Call

GlobeNewswire 3:00 PM NMSDC Recognizes 2024 Equity Honors Recipients

GlobeNewswire 12:00 AM Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 5/15 Lantheus Announces Executive Appointments to Accelerate Innovation

GlobeNewswire 5/15 Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VIS...

GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 5/6 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 5/2 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 4/2 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 3/6 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...

GlobeNewswire 3/4 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 2/2 Merck Group to expand investment in South Korea

TeleTrader 2/1 Merck's Q4 sales up 6% to $14.6B

TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 1/23 Unnatural Products, Inc. Enters Research Collaboration with Merck

GlobeNewswire 12/21/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 12/19/2023 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...

GlobeNewswire 12/14/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...

GlobeNewswire 12/12/2023 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...

GlobeNewswire 12/5/2023 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...

GlobeNewswire 12/4/2023 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

GlobeNewswire 11/13/2023 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TeleTrader 10/26/2023 Merck's Q3 sales up 7% to $16B

TeleTrader 10/20/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs

GlobeNewswire 10/17/2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA

BNP Paribas Discount Zert 6MK 24..../ DE000PC56UP7 /

If you wish to receive reply to your feedback, please provide your email address.